Search Results - "Lim, Dami"
-
1
Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease
Published in Future medicinal chemistry (01-08-2019)“…Interestingly, LMTX has shown initial promise as a monotherapy for mild-to-moderate AD patients who have not taken other AD drugs. [...]another Phase II/III…”
Get full text
Journal Article -
2
A Novel Phenylsulfonamide Ameliorates the Cognitive Impairment in Mice Induced by Scopolamine
Published in Bulletin of the Korean Chemical Society (2018)Get full text
Journal Article -
3
Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5‑a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease
Published in Journal of medicinal chemistry (12-01-2023)“…Dry eye disease (DED) is one of the most prevalent ocular diseases but has limited treatment options. Cystic fibrosis transmembrane conductance regulator…”
Get full text
Journal Article -
4
Development of tau-directed small molecule modulators for Alzheimer's disease: a recent patent review (2014-2018)
Published in Pharmaceutical patent analyst (01-01-2019)“…Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss and cognitive impairment. As this disease is becoming…”
Get full text
Journal Article -
5
A Novel Phenylsulfonamide Ameliorates the Cognitive Impairment in Mice Induced by Scopolamine
Published in Bulletin of the Korean Chemical Society (01-07-2018)“…KCI Citation Count: 1…”
Get full text
Journal Article